Literature DB >> 8395869

Prolonged oral etoposide in small cell lung cancer.

M L Slevin, S P Joel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8395869     DOI： 10.1093/oxfordjournals.annonc.a058583

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  2 in total

1.  Pharmacokinetically guided phase I trial of topotecan and etoposide phosphate in recurrent ovarian cancer.

Authors:  N C Levitt; D J Propper; S Madhusudan; J P Braybrooke; C Echeta; R Te Poele; S L Davies; E Flanagan; I D Hickson; S Joel; T S Ganesan
Journal:  Br J Cancer       Date:  2005-07-11       Impact factor: 7.640

2.  Enhanced oral bioavailability of an etoposide multiple nanoemulsion incorporating a deoxycholic acid derivative-lipid complex.

Authors:  Saurav Kumar Jha; Hee-Soo Han; Laxman Subedi; Rudra Pangeni; Jee Young Chung; Seho Kweon; Jeong Uk Choi; Youngro Byun; Yong-Hee Kim; Jin Woo Park
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.